Bio Path Holdings Inc reports results for the quarter ended in September - Earnings Summary

Bio Path Holdings

12/11/2021 12:00

* Bio Path Holdings Inc  BPTH.OQ  reported a quarterly adjusted
loss of 29 cents​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 33 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* The mean earnings estimate of analysts had risen by
about 10.8% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Bio Path Holdings Inc shares had fallen by 7.6% this
quarter and gained 35.4% so far this year.
* Wall Street's median 12-month price target for Bio Path
Holdings Inc is $12.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 12 at 12:00 p.m.
 ​All figures in US dollars unless otherwise stated